Keywords: new, ceo, merck, co, gilmartin, quits, plagued

New CEO for Merck & Co, as Gilmartin quits

Article | 16 May 2005

Print This

Merck & Co, plagued by the withdrawal of its leading COX-2 inhibitor Vioxx (rofecoxib) last year, has named Richard Clark as ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in